State-Identified Implementation Strategies to Increase Uptake of Immediate Postpartum Long-Acting Reversible Contraception Policies

Journal of Women's Health

Volumn 28, Issue 3, 2019, Pages 346-356

  Kroelinger, Charlan D ^a   Morgan, Isabel A ^a,b   Desisto, Carla L ^c   Estrich, Cameron ^c   Waddell, Lisa F ^d   MacKie, Christine ^d   Pliska, Ellen ^d   Goodman, David A ^a   Cox, Shanna ^a   Velonis, Alisa ^c   Rankin, Kristin M ^c  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b Health Services   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d ASSOCIATION OF STATE AND TERRITORIAL HEALTH OFFICIALS   (United States)

Author keywords

implementation strategies; Learning community; long acting reversible contraception; provider training; reimbursement; stakeholder partnerships

Indexed keywords

ADULT; ARTICLE; FEMALE; GENETIC TRANSCRIPTION; HUMAN; LEARNING; LONG-ACTING REVERSIBLE CONTRACEPTION; MONITORING; PUBLIC HEALTH SERVICE; QUALITATIVE ANALYSIS; REIMBURSEMENT; SEMI STRUCTURED INTERVIEW; UNPLANNED PREGNANCY; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH EDUCATION; MEDICAID; PREGNANCY; PROCEDURES; PUERPERIUM; UNITED STATES;

FEMALE; HEALTH EDUCATION; HEALTH PLAN IMPLEMENTATION; HEALTH POLICY; HUMANS; LONG-ACTING REVERSIBLE CONTRACEPTION; MEDICAID; POSTPARTUM PERIOD; PREGNANCY; UNITED STATES;

EID: 85062939080     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2018.7083     Document Type: Article

References (61)

1. Finer LB, Zolna MR. Declines in Unintended Pregnancy in the United States, 2008-2011. N Engl J Med 2016;374:843-852.
2. American College of Obstetricians and Gynecologists Committee on Health Care for Underserved Women. Committee Opinion No. 654: Reproductive Life Planning to Reduce Unintended Pregnancy. Obstet Gynecol 2016;127:e66-e69.
3. Birgisson NE, Zhao Q, Secura GM, Madden T, Peipert JF. Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review. J Womens Health (Larchmt) 2015;24:349-353.
4. Hall JA, Benton L, Copas A, Stephenson J. Pregnancy intention and pregnancy outcome: Systematic review and meta-analysis. Matern Child Health J 2017;21:670-704.
5. Kost K, Lindberg L. Pregnancy intentions, maternal behaviors, and infant health: Investigating relationships with new measures and propensity score analysis. Demography 2015;52:83-111.
6. Abajobir AA, Maravilla JC, Alati R, Najman JM. A systematic review and meta-analysis of the association between unintended pregnancy and perinatal depression. J Affect Disord 2016;192:56-63.
7. Cheng D, Schwarz EB, Douglas E, Horon I. Unintended pregnancy and associated maternal preconception, prenatal and postpartum behaviors. Contraception 2009;79:194-198.
8. Curtis KM, Tepper NK, Jatlaoui TC, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep 2016;65:1-103.
9. Stoddard A, McNicholas C, Peipert JF. Efficacy and safety of long-acting reversible contraception. Drugs 2011;71:969-980.
10. Hathaway M, Torres L, Vollett-Krech J, Wohltjen H. Increasing LARC utilization: Any woman, any place, any time. Clin Obstet Gynecol 2014;57:718-730.
11. Branum AM, Jones J. Trends in long-acting reversible contraception use among U.S. women aged 15-44. NCHS Data Brief 2015;188:1-8.
12. Kavanaugh ML, Jerman J. Contraceptive method use in the United States: Trends and characteristics between 2008, 2012 and 2014. Contraception 2018;97:14-21.
13. Gavin L, Frederiksen B, Robbins C, Pazol K, Moskosky S. New clinical performance measures for contraceptive care: Their importance to healthcare quality. Contraception 2017;96:149-157.
14. Boulet SL, D'Angelo DV, Morrow B, et al. Contraceptive Use Among Nonpregnant and Postpartum Women at Risk for Unintended Pregnancy, and Female High School Students, in the Context of Zika Preparedness-United States, 2011-2013 and 2015. MMWR Morb Mortal Wkly Rep 2016;65:780-787.
15. Thiel de Bocanegra H, Braughton M, Bradsberry M, Howell M, Logan J, Schwarz EB. Racial and ethnic disparities in postpartum care and contraception in California's Medicaid program. Am J Obstet Gynecol 2017;217:47.e1-47.e7.
16. Thiel de Bocanegra H, Chang R, Howell M, Darney P. Interpregnancy intervals: Impact of postpartum contraceptive effectiveness and coverage. Am J Obstet Gynecol 2014;210:311e311-e318.
17. Cohen R, Sheeder J, Arango N, Teal SB, Tocce K. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices. Contraception 2016;93:178-183.
18. Sonalkar S, Kapp N. Intrauterine device insertion in the postpartum period: A systematic review. Eur J Contracept Reprod Health Care 2015;20:4-18.
19. Woo I, Seifert S, Hendricks D, Jamshidi RM, Burke AE, Fox MC. Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices. Contraception 2015;92:532-535.
20. Jatlaoui TC, Riley HE, Curtis KM. The safety of intrauterine devices among young women: A systematic review. Contraception 2017;95:17-39.
21. American College of Obstetricians and Gynecologists, Committee on Obstetric Practice. Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception. Obstet Gynecol 2016;128:e32-e37.
22. Goldthwaite LM, Shaw KA. Immediate postpartum provision of long-acting reversible contraception. Curr Opin Obstet Gynecol 2015;27:460-464.
23. Washington CI, Jamshidi R, Thung SF, Nayeri UA, Caughey AB, Werner EF. Timing of postpartum intrauterine device placement: A cost-effectiveness analysis. Fertil Steril 2015;103:131-137.
24. Hofler LG, Cordes S, Cwiak CA, Goedken P, Jamieson DJ, Kottke M. Implementing immediate postpartum long-acting reversible contraception programs. Obstet Gynecol 2017;129:3-9.
25. Moniz MH, Roosevelt L, Crissman HP, et al. Immediate Postpartum Contraception: A Survey Needs Assessment of a National Sample of Midwives. J Midwifery Womens Health 2017 [Epub ahead of print]; DOI: 10.1111/jmwh.12653.
26. Moniz MH, Spector-Bagdady K, Heisler M, Harris LH. Inpatient postpartum long-acting reversible contraception: Care that promotes reproductive justice. Obstet Gynecol 2017;130:783-787.
27. Rauh-Benoit LA, Tepper NK, Zapata LB, et al. Healthcare provider attitudes of safety of intrauterine devices in the postpartum period. J Womens Health (Larchmt) 2016;26:768-773.
28. Pazol K, Robbins CL, Black LI, et al. Receipt of Selected Preventive Health Services for Women and Men of Reproductive Age-United States, 2011-2013. MMWR Surveill Summ 2017;66:1-31.
29. Vela VX, Patton EW, Sanghavi D, Wood SF, Shin P, Rosenbaum S. Rethinking medicaid coverage and payment policy to promote high value care: The case of long-acting reversible contraception. Womens Health Issues 2018;28:137-143.
30. Beeson T, Wood S, Bruen B, Goldberg DG, Mead H, Rosenbaum S. Accessibility of long-acting reversible contraceptives (LARCs) in Federally Qualified Health Centers (FQHCs). Contraception 2014;89:91-96.
31. Kroelinger CD, Waddell LF, Goodman DA, et al. Working with state health departments on emerging issues in maternal and child health: Immediate postpartum long-acting reversible contraceptives. J Womens Health (Larchmt) 2015;24:693-701.
32. Proctor EK, Powell BJ, McMillen JC. Implementation strategies: Recommendations for specifying and reporting. Implement Sci 2013;8:139.
33. DeSisto CL, Estrich C, Kroelinger CD, et al. Using a multi-state Learning Community as an implementation strategy for immediate postpartum long-acting reversible contraception. Implement Sci 2017;12:138.
34. Association of State and Territorial Health Officials. Long-Acting Reversible Contraception Learning Community Year Two In-Person Meeting Report 2015. http://www.astro.org/Maternal-and-Child-Health/Long-Acting-Reversible-Contraception/LARC-Immediately-Postpartum-Learning-Community-Background Accessed October 25, 2018
35. Web application for managing, analyzing, and presenting qualitative and mixed method research data. SocioCultural Research Consultants, LLC 2016. Available at: https://www.dedoose.com Accessed October 25, 2018.
36. Curtis KM, Jatlaoui TC, Tepper NK, et al. U.S. Selected Practice Recommendations for Contraceptive Use, 2016. MMWR Recomm Rep 2016;65:1-66.
37. Gavin L, Moskosky S, Carter M, et al. Providing quality family planning services: Recommendations of CDC and the U.S. Office of Population Affairs. MMWR Recomm Rep 2014;63(RR-04):1-54.
38. de Montigny JG, Desjardins S, Bouchard L. The fundamentals of cross-sector collaboration for social change to promote population health. Glob Health Promot 2017; e-pub on August 14, 2017. https://doi.org/10.1177/1757975917714036
39. Flood J, Minkler M, Hennessey Lavery S, Estrada J, Falbe J. The Collective Impact Model and Its Potential for Health Promotion: Overview and Case Study of a Healthy Retail Initiative in San Francisco. Health Educ Behav 2015;42:654-668.
40. Grumbach K, Vargas RA, Fleisher P, et al. Achieving Health Equity Through Community Engagement in Translating Evidence to Policy: The San Francisco Health Improvement Partnership, 2010-2016. Prev Chronic Dis 2017;14:E27.
41. Smith ML, Schneider EC, Byers IN, et al. Reported systems changes and sustainability perceptions of three state departments of health implementing multi-faceted evidence-based fall prevention efforts. Front Public Health 2017;5:120.
42. Harvey G, Loftus-Hills A, Rycroft-Malone J, et al. Getting evidence into practice: The role and function of facilitation. J Adv Nurs 2002;37:577-588.
43. Ash JS, Stavri PZ, Dykstra R, Fournier L. Implementing computerized physician order entry: The importance of special people. Int J Med Inform 2003;69:235-250.
44. Foley KL, Pockey JR, Helme DW, et al. Integrating evidence-based tobacco cessation interventions in free medical clinics: Opportunities and challenges. Health Promot Pract 2012;13:687-695.
45. Hadjistavropoulos T, Williams J, Kaasalainen S, Hunter PV, Savoie ML, Wickson-Griffiths A. Increasing the Frequency and Timeliness of Pain Assessment and Management in Long-Term Care: Knowledge Transfer and Sustained Implementation. Pain Res Manag 2016;2016:6493463.
46. Schmid AA, Andersen J, Kent T, Williams LS, Damush TM. Using intervention mapping to develop and adapt a secondary stroke prevention program in Veterans Health Administration medical centers. Implement Sci 2010;5:97.
47. Soo S, Berta W, Baker GR. Role of champions in the implementation of patient safety practice change. Healthc Q 2009;12 Spec No Patient:123-128.
48. Okoroh EM, Kane DJ, Gee RE, et al. Policy Change is Not Enough: Engaging Provider Champions on Immediate Postpartum Contraception. Am J Obstet Gynecol 2018;218:590.e1-590.e7.
49. Weiner BJ, Haynes-Maslow L, Kahwati LC, Kinsinger LS, Campbell MK. Implementing the MOVE! weight-management program in the Veterans Health Administration, 2007-2010: A qualitative study. Prev Chronic Dis 2012;9:E16.
50. National Collaborating Centre for Methods and Tools. Engaging public health champions to garner support for innovations, 2011. Available at: www.nccmt.ca/resources/search/91 Accessed October 25, 2018.
51. Howell JM, Shea CM, Higgins CA. Champions of product innovations: Defining, developing, and validating a measure of champion behavior. J Business Venturing 2005;20:641-661.
52. Evans T, Ramaswamy M, Satterwhite CL. Availability of Long-Acting Reversible Contraception in Kansas Health Departments. J Rural Health 2017;34:132-137.
53. Vaaler ML, Kalanges LK, Fonseca VP, Castrucci BC. Urban-rural differences in attitudes and practices toward long-acting reversible contraceptives among family planning providers in Texas. Womens Health Issues 2012;22:e157-e162.
54. Moniz MH, McEvoy AK, Hofmeister M, Plegue M, Chang T. Family Physicians and Provision of Immediate Postpartum Contraception: A CERA Study. Fam Med 2017;49:600-606.
55. Moniz MH, Chang T, Davis MM, Forman J, Landgraf J, Dalton VK. Medicaid Administrator Experiences with the IMplementation of Immediate Postpartum Long-Acting Reversible Contraception. Womens Health Issues 2016;26:313-320.
56. Berlan ED, Pritt NM, Norris AH. Pediatricians' Attitudes and Beliefs about Long-Acting Reversible Contraceptives Influence Counseling. J Pediatr Adolesc Gynecol 2017;30:47-52.
57. Tyler CP, Whiteman MK, Zapata LB, Curtis KM, Hillis SD, Marchbanks PA. Health care provider attitudes and practices related to intrauterine devices for nulliparous women. Obstet Gynecol 2012;119:762-771.
58. Benfield N, Hawkins F, Ray L, et al. Exposure to routine availability of immediate postpartum LARC: Effect on attitudes and practices of labor and delivery and postpartum nurses. Contraception 2018;97:411-414.
59. Park HY, Rodriguez MI, Hulett D, Darney PD, Thiel de Bocanegra H. Long-acting reversible contraception method use among Title X providers and non-Title X providers in California. Contraception 2012;86:557-561.
60. American College of Obstetricians and Gynecologists Committee on Gynecologic Practice, Long-Acting Reversible Contraceptive Expert Work Group. Committee Opinion No 672: Clinical Challenges of Long-Acting Reversible Contraceptive Methods. Obstet Gynecol 2016;128:e69-e77.
61. Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: Conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health 2011;38:65-76.